Advertisement
UK markets open in 2 hours 27 minutes
  • NIKKEI 225

    38,367.84
    +815.68 (+2.17%)
     
  • HANG SENG

    17,110.21
    +281.28 (+1.67%)
     
  • CRUDE OIL

    83.44
    +0.08 (+0.10%)
     
  • GOLD FUTURES

    2,340.20
    -1.90 (-0.08%)
     
  • DOW

    38,503.69
    +263.71 (+0.69%)
     
  • Bitcoin GBP

    53,594.70
    +267.96 (+0.50%)
     
  • CMC Crypto 200

    1,436.40
    +21.64 (+1.53%)
     
  • NASDAQ Composite

    15,696.64
    +245.33 (+1.59%)
     
  • UK FTSE All Share

    4,378.75
    +16.15 (+0.37%)
     

Why Incyte Stock Fell ~9% on April 24

Why Incyte Stock Fell ~9% on April 24

On April 24, Incyte (INCY) saw a steep decline in its stock price. It registered a decline of ~5% during pre-market trading. The stock price decline was triggered by the news regarding Incyte-Eli Lily (LLY) drug Baricitinib, which is under FDA (U.S. Food and Drug Administration) review.